VYGLEA Trademark

Trademark Overview

On Wednesday, December 20, 2017, a trademark application was filed for VYGLEA with the United States Patent and Trademark Office. The USPTO has given the VYGLEA trademark a serial number of 87729233. The federal status of this trademark filing is REGISTERED as of Tuesday, December 12, 2023. This trademark is owned by Biohaven Pharmaceutical Holding Company Limited. The VYGLEA trademark is filed in the Pharmaceutical Products category with the following description:

Medicated and pharmaceutical preparations, both prescription and over-the-counter, for use in connection with humans and animals, namely, for the treatment of central nervous system disorders, neurologic illnesses, and psychiatric illnesses pharmaceutical preparations for the treatment of neurodegenerative diseases; pharmaceutical preparations for the treatment of neurodegenerative diseases, namely, Alzheimer's disease (AD), frontotemporal dementia, cognitive impairment of aging, pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of pain, namely, chronic neuropathic pain, peripheral neuropathy, pharmaceutical preparations for symptomatic treatments of degenerative diseases; pharmaceutical preparations for symptomatic treatments of degenerative diseases, namely, dystonias, dysphagia, gait abnormalities, bulbar function in ALS, agitation in AD, disinhibition in dementia; pharmaceutical preparations for the treatment of neuropsychiatric di...
vyglea

General Information

Serial Number87729233
Word MarkVYGLEA
Filing DateWednesday, December 20, 2017
Status700 - REGISTERED
Status DateTuesday, December 12, 2023
Registration Number7242841
Registration DateTuesday, December 12, 2023
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 30, 2018

Trademark Statements

Goods and ServicesMedicated and pharmaceutical preparations, both prescription and over-the-counter, for use in connection with humans and animals, namely, for the treatment of central nervous system disorders, neurologic illnesses, and psychiatric illnesses pharmaceutical preparations for the treatment of neurodegenerative diseases; pharmaceutical preparations for the treatment of neurodegenerative diseases, namely, Alzheimer's disease (AD), frontotemporal dementia, cognitive impairment of aging, pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of pain, namely, chronic neuropathic pain, peripheral neuropathy, pharmaceutical preparations for symptomatic treatments of degenerative diseases; pharmaceutical preparations for symptomatic treatments of degenerative diseases, namely, dystonias, dysphagia, gait abnormalities, bulbar function in ALS, agitation in AD, disinhibition in dementia; pharmaceutical preparations for the treatment of neuropsychiatric disorders; pharmaceutical preparations for the treatment of neuropsychiatric disorders, namely, Obsessive Compulsive Disorder (OCD), Generalized Anxiety Disorder (GAD), pharmaceutical preparations for the treatment of cerebellar disorders; pharmaceutical preparations for the treatment of cerebellar disorders, namely, spinocerebellar ataxia, pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer, namely, adjunctive use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 8, 2018
Primary Code005
First Use Anywhere DateFriday, June 30, 2023
First Use In Commerce DateFriday, June 30, 2023

Trademark Owner History

Party NameBIOHAVEN THERAPEUTICS LTD.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressRoad Town, Tortola VG1110
VG
Party NameBIOHAVEN THERAPEUTICS LTD.
Party Type22 - New Owner After Publication
Legal Entity Type99 - Other
AddressRoad Town, Tortola VG1110
VG
Party NameBIOHAVEN LIMITED
Party Type21 - New Owner After Publication
Legal Entity Type99 - Other
AddressNEW HAVEN, CT 06510
Party NameBiohaven Pharmaceutical Holding Company Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressNew Haven, CT 06510
Party NameBiohaven Pharmaceutical Holding Company Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressNew Haven, CT 06510

Trademark Events

Event DateEvent Description
Thursday, March 29, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, December 23, 2017NEW APPLICATION ENTERED
Monday, January 8, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 27, 2018ASSIGNED TO EXAMINER
Thursday, March 29, 2018NON-FINAL ACTION WRITTEN
Thursday, March 29, 2018NON-FINAL ACTION E-MAILED
Thursday, August 30, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 30, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 31, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 6, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 21, 2018ASSIGNED TO LIE
Wednesday, October 10, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 30, 2018PUBLISHED FOR OPPOSITION
Tuesday, October 30, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, November 28, 2018EXTENSION OF TIME TO OPPOSE RECEIVED
Wednesday, February 27, 2019OPPOSITION INSTITUTED NO. 999999
Wednesday, October 23, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 23, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 10, 2020TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, July 9, 2020OPPOSITION TERMINATED NO. 999999
Thursday, July 9, 2020OPPOSITION DISMISSED NO. 999999
Thursday, July 9, 2020TTAB RELEASE CASE TO TRADEMARKS
Tuesday, August 18, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, February 12, 2021SOU TEAS EXTENSION RECEIVED
Friday, February 12, 2021SOU EXTENSION 1 FILED
Friday, February 12, 2021SOU EXTENSION 1 GRANTED
Tuesday, February 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 12, 2021SOU TEAS EXTENSION RECEIVED
Thursday, August 12, 2021SOU EXTENSION 2 FILED
Thursday, August 12, 2021SOU EXTENSION 2 GRANTED
Saturday, August 14, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 16, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, February 16, 2022SOU EXTENSION 3 FILED
Wednesday, February 16, 2022SOU EXTENSION 3 GRANTED
Friday, February 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 18, 2022SOU TEAS EXTENSION RECEIVED
Thursday, August 18, 2022SOU EXTENSION 4 FILED
Thursday, August 18, 2022SOU EXTENSION 4 GRANTED
Saturday, August 20, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 11, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, February 15, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Friday, February 17, 2023SOU TEAS EXTENSION RECEIVED
Friday, February 17, 2023SOU EXTENSION 5 FILED
Wednesday, March 1, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, March 3, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 6, 2023SOU EXTENSION 5 GRANTED
Tuesday, March 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 17, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, April 17, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 17, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, August 16, 2023TEAS STATEMENT OF USE RECEIVED
Wednesday, August 16, 2023USE AMENDMENT FILED
Wednesday, August 23, 2023STATEMENT OF USE PROCESSING COMPLETE
Tuesday, November 7, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, November 8, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, December 12, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, December 12, 2023REGISTERED-PRINCIPAL REGISTER

Related Keywords

vyglea pharmaceutical preparations treatment diseases namely pain neurodegenerative treatments dementia illnesses